20-Jan-2026
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
Business Wire (Mon, 12-Jan 8:30 AM ET)
Market Chameleon (Mon, 12-Jan 2:07 AM ET)
Northwestern Medicine Selects Tempus to Expand Genomic Testing
Business Wire (Mon, 12-Jan 7:00 AM ET)
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
Business Wire (Sun, 11-Jan 5:30 PM ET)
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
Business Wire (Sun, 11-Jan 5:00 PM ET)
Business Wire (Thu, 8-Jan 8:30 AM ET)
Market Chameleon (Tue, 6-Jan 3:37 AM ET)
Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference
Business Wire (Tue, 6-Jan 8:30 AM ET)
Business Wire (Tue, 9-Dec 8:30 AM ET)
Tempus Prepares to Spotlight AI Precision Medicine at Piper Sandler Healthcare Conference
Market Chameleon (Tue, 18-Nov 3:47 AM ET)
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Tempus Ai - Class A trades on the NASDAQ stock market under the symbol TEM.
As of January 20, 2026, TEM stock price declined to $66.78 with 4,238,466 million shares trading.
TEM has a beta of 2.23, meaning it tends to be more sensitive to market movements. TEM has a correlation of 0.18 to the broad based SPY ETF.
TEM has a market cap of $11.60 billion. This is considered a Large Cap stock.
Last quarter Tempus Ai - Class A reported $334 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.14.
The top ETF exchange traded funds that TEM belongs to (by Net Assets): ARKK, VTI, VB, ARKG, VBK.
TEM has outperformed the market in the last year with a price return of +92.2% while the SPY ETF gained +15.8%. However, in the short term, TEM had mixed performance relative to the market. It has underperformed in the last 3 months, returning -26.6% vs +2.9% return in SPY. But in the last 2 weeks, TEM shares have fared better than the market returning +7.1% compared to SPY -0.8%.
TEM support price is $67.22 and resistance is $73.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TEM shares will trade within this expected range on the day.